Titan Medical Inc. is a Canadian medical device company focused on the design, development and future commercialization of a single-port robotic surgical system. The company’s flagship platform, the Sport™ Surgical System, is engineered to provide surgeons with a minimally invasive solution that utilizes a single access point. By integrating multi-articulated instruments with three-dimensional high-definition visualization, Titan Medical aims to offer enhanced dexterity, precision and ergonomics compared with traditional multi-port robotic systems.
The Sport Surgical System is being developed to address a range of procedures across urology, gynecology and general surgery. Titan Medical has conducted preclinical feasibility studies to validate the platform’s instrument reach and articulation. The system’s design emphasizes a compact footprint in the operating room, intuitive surgeon controls and streamlined instrument exchanges—all intended to help reduce operating time and improve patient recovery outcomes.
Headquartered in Toronto, Ontario, Titan Medical serves a global marketplace with initial focus on North America and Europe. The company is pursuing regulatory clearances, including U.S. Food and Drug Administration and CE mark approvals, with plans to engage surgical centers and hospital networks upon market entry. Titan Medical also seeks strategic partnerships for distribution and clinical partnerships to support adoption and training.
Under the leadership of President and Chief Executive Officer Scott Huennekens, Titan Medical continues to advance its development milestones and manufacturing preparations. As a Nasdaq-listed company trading under the symbol TMDIF, Titan Medical is dedicated to driving innovation in single-incision robotic surgery and expanding the accessibility of minimally invasive solutions.
AI Generated. May Contain Errors.
Free TMDIF Stock Alerts